Search Login Register
docetaxel
(Taxotere)
Summary
Description:
semisynthetic analog of taxol; structure given in first source; RN given refers to anhydrous compound; 148408-66-6 is the isomer (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,12alpha,12aalpha,12balpha))
Also Known As:
Taxotere; N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol; NSC 628503; RP 56976; RP-56976 Show All >>
Networked: 7054
relevant articles (1203 outcomes,
2849 trials/studies)
for this Drug
Key Diseases for which docetaxel is
Relevant
-
Breast Neoplasms (Breast Cancer)
:
313 outcomes 780 studies in 1695 results
-
Prostatic Neoplasms (Prostate Cancer)
:
228 outcomes 459 studies in 1363 results
-
Neoplasms (Cancer)
:
210 outcomes 467 studies in 1777 results
-
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
:
133 outcomes 501 studies in 888 results
-
Stomach Neoplasms (Stomach Cancer)
:
87 outcomes 169 studies in 434 results
Show All >>
Drugs Related to docetaxel
-
Cisplatin (Platino)
-
docetaxel (Taxotere)
-
gemcitabine
-
Paclitaxel (Taxol)
-
Fluorouracil (Carac)
-
Hormones
-
capecitabine (Xeloda)
-
Carboplatin (JM8)
-
trastuzumab (Herceptin)
-
Doxorubicin (Adriamycin)
Show All >>
Therapies Related to docetaxel
-
Drug Therapy (Chemotherapy)
-
Castration
-
Combination Drug Therapy (Combination Chemotherapy)
-
Heterologous Transplantation (Xenotransplantation)
-
Radiotherapy
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.